Last reviewed · How we verify

NCT07528833

Health Effects of Mindfulness Based Stress Reduction Course in Treatment of Back Pain

Recruiting now NA Last updated 14 April 2026
What this trial tests

NA trial testing Mindfulness based stress reduction (MBSR) course in Back Pain in 120 participants. Currently enrolling.

Timeline
1 January 2025
Primary endpoint
1 January 2030
1 January 2030

Quick facts

Lead sponsorTampere University Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment120
Start date1 January 2025
Primary completion1 January 2030
Estimated completion1 January 2030
Sites4 locations across Finland

Drugs / interventions tested

Conditions studied

Sponsor

Tampere University Hospital

Who can join

Adults 18 to 64, any sex, with Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* Health effects of mindfulness based stress reduction course versus usual care in treatment of back pain: a randomized clinical trial * Mindfulness based stress reduction (MBSR) course intervention for half of the research patients * MBSR course lasts for 8 weeks. * follow-up time 2 years. * research data is collected by Recdap * Working-age (18-64 years) patients with back pain in thoracal or lumbar area (NRS at least 4) with or without radiculation over 12 weeks will be recruited. * The primary outcome measure is Numeric pain rating scale (NRS, 0-10).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Back Pain

Currently open trials in the same condition.

Other Tampere University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07528833.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing